nodes	percent_of_prediction	percent_of_DWPC	metapath
Orciprenaline—Insomnia—Pentoxifylline—systemic scleroderma	0.0046	0.0046	CcSEcCtD
Orciprenaline—Nervousness—Captopril—systemic scleroderma	0.00459	0.00459	CcSEcCtD
Orciprenaline—Chest pain—Mometasone—systemic scleroderma	0.00458	0.00458	CcSEcCtD
Orciprenaline—Myalgia—Mometasone—systemic scleroderma	0.00458	0.00458	CcSEcCtD
Orciprenaline—Sweating—Mycophenolic acid—systemic scleroderma	0.00456	0.00456	CcSEcCtD
Orciprenaline—Somnolence—Pentoxifylline—systemic scleroderma	0.00452	0.00452	CcSEcCtD
Orciprenaline—Dry mouth—Mometasone—systemic scleroderma	0.00448	0.00448	CcSEcCtD
Orciprenaline—Vision blurred—Captopril—systemic scleroderma	0.00445	0.00445	CcSEcCtD
Orciprenaline—Hypokalaemia—Mycophenolate mofetil—systemic scleroderma	0.00443	0.00443	CcSEcCtD
Orciprenaline—Anaphylactic shock—Mometasone—systemic scleroderma	0.00439	0.00439	CcSEcCtD
Orciprenaline—Chills—Azathioprine—systemic scleroderma	0.00425	0.00425	CcSEcCtD
Orciprenaline—Syncope—Captopril—systemic scleroderma	0.00424	0.00424	CcSEcCtD
Orciprenaline—Arrhythmia—Azathioprine—systemic scleroderma	0.00423	0.00423	CcSEcCtD
Orciprenaline—Asthma—Mycophenolate mofetil—systemic scleroderma	0.00421	0.00421	CcSEcCtD
Orciprenaline—Influenza—Mycophenolate mofetil—systemic scleroderma	0.00421	0.00421	CcSEcCtD
Orciprenaline—Palpitations—Captopril—systemic scleroderma	0.00417	0.00417	CcSEcCtD
Orciprenaline—Loss of consciousness—Captopril—systemic scleroderma	0.00415	0.00415	CcSEcCtD
Orciprenaline—Cough—Captopril—systemic scleroderma	0.00412	0.00412	CcSEcCtD
Orciprenaline—Sweating—Lisinopril—systemic scleroderma	0.0041	0.0041	CcSEcCtD
Orciprenaline—Urticaria—Pentoxifylline—systemic scleroderma	0.00404	0.00404	CcSEcCtD
Orciprenaline—Chest pain—Captopril—systemic scleroderma	0.00402	0.00402	CcSEcCtD
Orciprenaline—Myalgia—Captopril—systemic scleroderma	0.00402	0.00402	CcSEcCtD
Orciprenaline—Body temperature increased—Pentoxifylline—systemic scleroderma	0.00402	0.00402	CcSEcCtD
Orciprenaline—Chills—Leflunomide—systemic scleroderma	0.00401	0.00401	CcSEcCtD
Orciprenaline—Musculoskeletal discomfort—Mometasone—systemic scleroderma	0.004	0.004	CcSEcCtD
Orciprenaline—Arrhythmia—Leflunomide—systemic scleroderma	0.00399	0.00399	CcSEcCtD
Orciprenaline—Dry mouth—Captopril—systemic scleroderma	0.00393	0.00393	CcSEcCtD
Orciprenaline—Anaphylactic shock—Captopril—systemic scleroderma	0.00385	0.00385	CcSEcCtD
Orciprenaline—Chills—Mycophenolic acid—systemic scleroderma	0.00383	0.00383	CcSEcCtD
Orciprenaline—Dysgeusia—Leflunomide—systemic scleroderma	0.00381	0.00381	CcSEcCtD
Orciprenaline—Arrhythmia—Mycophenolic acid—systemic scleroderma	0.00381	0.00381	CcSEcCtD
Orciprenaline—Shock—Captopril—systemic scleroderma	0.00379	0.00379	CcSEcCtD
Orciprenaline—Fatigue—Mometasone—systemic scleroderma	0.00378	0.00378	CcSEcCtD
Orciprenaline—Tachycardia—Captopril—systemic scleroderma	0.00376	0.00376	CcSEcCtD
Orciprenaline—Pain—Mometasone—systemic scleroderma	0.00375	0.00375	CcSEcCtD
Orciprenaline—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.00375	0.00375	CcSEcCtD
Orciprenaline—Muscle spasms—Leflunomide—systemic scleroderma	0.00374	0.00374	CcSEcCtD
Orciprenaline—Vision blurred—Leflunomide—systemic scleroderma	0.00367	0.00367	CcSEcCtD
Orciprenaline—Asthenia—Pentoxifylline—systemic scleroderma	0.00365	0.00365	CcSEcCtD
Orciprenaline—Tension—Mycophenolic acid—systemic scleroderma	0.00364	0.00364	CcSEcCtD
Orciprenaline—Nervousness—Mycophenolic acid—systemic scleroderma	0.00361	0.00361	CcSEcCtD
Orciprenaline—Pruritus—Pentoxifylline—systemic scleroderma	0.0036	0.0036	CcSEcCtD
Orciprenaline—Sweating—Mycophenolate mofetil—systemic scleroderma	0.0036	0.0036	CcSEcCtD
Orciprenaline—Muscle spasms—Mycophenolic acid—systemic scleroderma	0.00357	0.00357	CcSEcCtD
Orciprenaline—Musculoskeletal discomfort—Captopril—systemic scleroderma	0.00351	0.00351	CcSEcCtD
Orciprenaline—Myalgia—Azathioprine—systemic scleroderma	0.00351	0.00351	CcSEcCtD
Orciprenaline—Vision blurred—Mycophenolic acid—systemic scleroderma	0.0035	0.0035	CcSEcCtD
Orciprenaline—Insomnia—Captopril—systemic scleroderma	0.00349	0.00349	CcSEcCtD
Orciprenaline—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00348	0.00348	CcSEcCtD
Orciprenaline—Tremor—Mycophenolic acid—systemic scleroderma	0.00348	0.00348	CcSEcCtD
Orciprenaline—Body temperature increased—Mometasone—systemic scleroderma	0.00347	0.00347	CcSEcCtD
Orciprenaline—Chills—Lisinopril—systemic scleroderma	0.00345	0.00345	CcSEcCtD
Orciprenaline—Palpitations—Leflunomide—systemic scleroderma	0.00344	0.00344	CcSEcCtD
Orciprenaline—Arrhythmia—Lisinopril—systemic scleroderma	0.00343	0.00343	CcSEcCtD
Orciprenaline—Somnolence—Captopril—systemic scleroderma	0.00343	0.00343	CcSEcCtD
Orciprenaline—Cough—Leflunomide—systemic scleroderma	0.0034	0.0034	CcSEcCtD
Orciprenaline—Dizziness—Pentoxifylline—systemic scleroderma	0.00336	0.00336	CcSEcCtD
Orciprenaline—Hypertension—Leflunomide—systemic scleroderma	0.00336	0.00336	CcSEcCtD
Orciprenaline—Syncope—Mycophenolic acid—systemic scleroderma	0.00333	0.00333	CcSEcCtD
Orciprenaline—Fatigue—Captopril—systemic scleroderma	0.00332	0.00332	CcSEcCtD
Orciprenaline—Chest pain—Leflunomide—systemic scleroderma	0.00331	0.00331	CcSEcCtD
Orciprenaline—Myalgia—Leflunomide—systemic scleroderma	0.00331	0.00331	CcSEcCtD
Orciprenaline—Tension—Lisinopril—systemic scleroderma	0.00328	0.00328	CcSEcCtD
Orciprenaline—Palpitations—Mycophenolic acid—systemic scleroderma	0.00328	0.00328	CcSEcCtD
Orciprenaline—Dysgeusia—Lisinopril—systemic scleroderma	0.00328	0.00328	CcSEcCtD
Orciprenaline—Loss of consciousness—Mycophenolic acid—systemic scleroderma	0.00326	0.00326	CcSEcCtD
Orciprenaline—Nervousness—Lisinopril—systemic scleroderma	0.00325	0.00325	CcSEcCtD
Orciprenaline—Dry mouth—Leflunomide—systemic scleroderma	0.00324	0.00324	CcSEcCtD
Orciprenaline—Cough—Mycophenolic acid—systemic scleroderma	0.00324	0.00324	CcSEcCtD
Orciprenaline—Vomiting—Pentoxifylline—systemic scleroderma	0.00323	0.00323	CcSEcCtD
Orciprenaline—Muscle spasms—Lisinopril—systemic scleroderma	0.00322	0.00322	CcSEcCtD
Orciprenaline—Hypertension—Mycophenolic acid—systemic scleroderma	0.00321	0.00321	CcSEcCtD
Orciprenaline—Headache—Pentoxifylline—systemic scleroderma	0.00319	0.00319	CcSEcCtD
Orciprenaline—Anaphylactic shock—Leflunomide—systemic scleroderma	0.00318	0.00318	CcSEcCtD
Orciprenaline—Myalgia—Mycophenolic acid—systemic scleroderma	0.00316	0.00316	CcSEcCtD
Orciprenaline—Chest pain—Mycophenolic acid—systemic scleroderma	0.00316	0.00316	CcSEcCtD
Orciprenaline—Vision blurred—Lisinopril—systemic scleroderma	0.00315	0.00315	CcSEcCtD
Orciprenaline—Asthenia—Mometasone—systemic scleroderma	0.00315	0.00315	CcSEcCtD
Orciprenaline—Tremor—Lisinopril—systemic scleroderma	0.00313	0.00313	CcSEcCtD
Orciprenaline—Pruritus—Mometasone—systemic scleroderma	0.00311	0.00311	CcSEcCtD
Orciprenaline—Tachycardia—Leflunomide—systemic scleroderma	0.0031	0.0031	CcSEcCtD
Orciprenaline—Dry mouth—Mycophenolic acid—systemic scleroderma	0.00309	0.00309	CcSEcCtD
Orciprenaline—Hyperhidrosis—Leflunomide—systemic scleroderma	0.00307	0.00307	CcSEcCtD
Orciprenaline—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.00307	0.00307	CcSEcCtD
Orciprenaline—Body temperature increased—Captopril—systemic scleroderma	0.00305	0.00305	CcSEcCtD
Orciprenaline—Oedema—Mycophenolic acid—systemic scleroderma	0.00303	0.00303	CcSEcCtD
Orciprenaline—Nausea—Pentoxifylline—systemic scleroderma	0.00302	0.00302	CcSEcCtD
Orciprenaline—Chills—Mycophenolate mofetil—systemic scleroderma	0.00302	0.00302	CcSEcCtD
Orciprenaline—Arrhythmia—Mycophenolate mofetil—systemic scleroderma	0.00301	0.00301	CcSEcCtD
Orciprenaline—Diarrhoea—Mometasone—systemic scleroderma	0.003	0.003	CcSEcCtD
Orciprenaline—Hypokalaemia—Prednisone—systemic scleroderma	0.003	0.003	CcSEcCtD
Orciprenaline—Syncope—Lisinopril—systemic scleroderma	0.003	0.003	CcSEcCtD
Orciprenaline—Shock—Mycophenolic acid—systemic scleroderma	0.00298	0.00298	CcSEcCtD
Orciprenaline—Tachycardia—Mycophenolic acid—systemic scleroderma	0.00296	0.00296	CcSEcCtD
Orciprenaline—Palpitations—Lisinopril—systemic scleroderma	0.00296	0.00296	CcSEcCtD
Orciprenaline—Loss of consciousness—Lisinopril—systemic scleroderma	0.00294	0.00294	CcSEcCtD
Orciprenaline—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.00293	0.00293	CcSEcCtD
Orciprenaline—Cough—Lisinopril—systemic scleroderma	0.00292	0.00292	CcSEcCtD
Orciprenaline—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.00289	0.00289	CcSEcCtD
Orciprenaline—Tension—Mycophenolate mofetil—systemic scleroderma	0.00288	0.00288	CcSEcCtD
Orciprenaline—Insomnia—Leflunomide—systemic scleroderma	0.00287	0.00287	CcSEcCtD
Orciprenaline—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	0.00287	0.00287	CcSEcCtD
Orciprenaline—Anaphylactoid reaction—Methotrexate—systemic scleroderma	0.00285	0.00285	CcSEcCtD
Orciprenaline—Chest pain—Lisinopril—systemic scleroderma	0.00285	0.00285	CcSEcCtD
Orciprenaline—Myalgia—Lisinopril—systemic scleroderma	0.00285	0.00285	CcSEcCtD
Orciprenaline—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.00285	0.00285	CcSEcCtD
Orciprenaline—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.00282	0.00282	CcSEcCtD
Orciprenaline—Vomiting—Mometasone—systemic scleroderma	0.00279	0.00279	CcSEcCtD
Orciprenaline—Dry mouth—Lisinopril—systemic scleroderma	0.00279	0.00279	CcSEcCtD
Orciprenaline—Sweating increased—Prednisone—systemic scleroderma	0.00278	0.00278	CcSEcCtD
Orciprenaline—Asthenia—Captopril—systemic scleroderma	0.00277	0.00277	CcSEcCtD
Orciprenaline—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.00276	0.00276	CcSEcCtD
Orciprenaline—Headache—Mometasone—systemic scleroderma	0.00275	0.00275	CcSEcCtD
Orciprenaline—Tremor—Mycophenolate mofetil—systemic scleroderma	0.00275	0.00275	CcSEcCtD
Orciprenaline—Insomnia—Mycophenolic acid—systemic scleroderma	0.00274	0.00274	CcSEcCtD
Orciprenaline—Fatigue—Leflunomide—systemic scleroderma	0.00274	0.00274	CcSEcCtD
Orciprenaline—Oedema—Lisinopril—systemic scleroderma	0.00273	0.00273	CcSEcCtD
Orciprenaline—Anaphylactic shock—Lisinopril—systemic scleroderma	0.00273	0.00273	CcSEcCtD
Orciprenaline—Pruritus—Captopril—systemic scleroderma	0.00273	0.00273	CcSEcCtD
Orciprenaline—Pain—Leflunomide—systemic scleroderma	0.00272	0.00272	CcSEcCtD
Orciprenaline—Somnolence—Mycophenolic acid—systemic scleroderma	0.00269	0.00269	CcSEcCtD
Orciprenaline—Shock—Lisinopril—systemic scleroderma	0.00269	0.00269	CcSEcCtD
Orciprenaline—Tachycardia—Lisinopril—systemic scleroderma	0.00266	0.00266	CcSEcCtD
Orciprenaline—Body temperature increased—Azathioprine—systemic scleroderma	0.00266	0.00266	CcSEcCtD
Orciprenaline—Hyperhidrosis—Lisinopril—systemic scleroderma	0.00264	0.00264	CcSEcCtD
Orciprenaline—Diarrhoea—Captopril—systemic scleroderma	0.00264	0.00264	CcSEcCtD
Orciprenaline—Syncope—Mycophenolate mofetil—systemic scleroderma	0.00263	0.00263	CcSEcCtD
Orciprenaline—Fatigue—Mycophenolic acid—systemic scleroderma	0.00261	0.00261	CcSEcCtD
Orciprenaline—Nausea—Mometasone—systemic scleroderma	0.00261	0.00261	CcSEcCtD
Orciprenaline—Pain—Mycophenolic acid—systemic scleroderma	0.00259	0.00259	CcSEcCtD
Orciprenaline—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.00259	0.00259	CcSEcCtD
Orciprenaline—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.00258	0.00258	CcSEcCtD
Orciprenaline—Cough—Mycophenolate mofetil—systemic scleroderma	0.00256	0.00256	CcSEcCtD
Orciprenaline—Dizziness—Captopril—systemic scleroderma	0.00255	0.00255	CcSEcCtD
Orciprenaline—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.00253	0.00253	CcSEcCtD
Orciprenaline—Urticaria—Leflunomide—systemic scleroderma	0.00252	0.00252	CcSEcCtD
Orciprenaline—Body temperature increased—Leflunomide—systemic scleroderma	0.00251	0.00251	CcSEcCtD
Orciprenaline—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.0025	0.0025	CcSEcCtD
Orciprenaline—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.0025	0.0025	CcSEcCtD
Orciprenaline—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.00249	0.00249	CcSEcCtD
Orciprenaline—Hypersensitivity—Azathioprine—systemic scleroderma	0.00248	0.00248	CcSEcCtD
Orciprenaline—Insomnia—Lisinopril—systemic scleroderma	0.00247	0.00247	CcSEcCtD
Orciprenaline—Vomiting—Captopril—systemic scleroderma	0.00245	0.00245	CcSEcCtD
Orciprenaline—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.00244	0.00244	CcSEcCtD
Orciprenaline—Somnolence—Lisinopril—systemic scleroderma	0.00243	0.00243	CcSEcCtD
Orciprenaline—Headache—Captopril—systemic scleroderma	0.00241	0.00241	CcSEcCtD
Orciprenaline—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.0024	0.0024	CcSEcCtD
Orciprenaline—Oedema—Mycophenolate mofetil—systemic scleroderma	0.00239	0.00239	CcSEcCtD
Orciprenaline—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.00239	0.00239	CcSEcCtD
Orciprenaline—Asthma—Methotrexate—systemic scleroderma	0.00238	0.00238	CcSEcCtD
Orciprenaline—Fatigue—Lisinopril—systemic scleroderma	0.00235	0.00235	CcSEcCtD
Orciprenaline—Shock—Mycophenolate mofetil—systemic scleroderma	0.00235	0.00235	CcSEcCtD
Orciprenaline—Hypersensitivity—Leflunomide—systemic scleroderma	0.00234	0.00234	CcSEcCtD
Orciprenaline—Pain—Lisinopril—systemic scleroderma	0.00233	0.00233	CcSEcCtD
Orciprenaline—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.00233	0.00233	CcSEcCtD
Orciprenaline—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.00231	0.00231	CcSEcCtD
Orciprenaline—Diarrhoea—Azathioprine—systemic scleroderma	0.0023	0.0023	CcSEcCtD
Orciprenaline—Nausea—Captopril—systemic scleroderma	0.00229	0.00229	CcSEcCtD
Orciprenaline—Abdominal discomfort—Methotrexate—systemic scleroderma	0.00228	0.00228	CcSEcCtD
Orciprenaline—Asthenia—Leflunomide—systemic scleroderma	0.00228	0.00228	CcSEcCtD
Orciprenaline—Pruritus—Leflunomide—systemic scleroderma	0.00225	0.00225	CcSEcCtD
Orciprenaline—Dizziness—Azathioprine—systemic scleroderma	0.00222	0.00222	CcSEcCtD
Orciprenaline—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.00218	0.00218	CcSEcCtD
Orciprenaline—Asthenia—Mycophenolic acid—systemic scleroderma	0.00217	0.00217	CcSEcCtD
Orciprenaline—Diarrhoea—Leflunomide—systemic scleroderma	0.00217	0.00217	CcSEcCtD
Orciprenaline—Urticaria—Lisinopril—systemic scleroderma	0.00217	0.00217	CcSEcCtD
Orciprenaline—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.00216	0.00216	CcSEcCtD
Orciprenaline—Body temperature increased—Lisinopril—systemic scleroderma	0.00216	0.00216	CcSEcCtD
Orciprenaline—Pruritus—Mycophenolic acid—systemic scleroderma	0.00214	0.00214	CcSEcCtD
Orciprenaline—Vomiting—Azathioprine—systemic scleroderma	0.00214	0.00214	CcSEcCtD
Orciprenaline—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.00213	0.00213	CcSEcCtD
Orciprenaline—Drowsiness—Methotrexate—systemic scleroderma	0.00212	0.00212	CcSEcCtD
Orciprenaline—Headache—Azathioprine—systemic scleroderma	0.00211	0.00211	CcSEcCtD
Orciprenaline—Dizziness—Leflunomide—systemic scleroderma	0.0021	0.0021	CcSEcCtD
Orciprenaline—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00207	0.00207	CcSEcCtD
Orciprenaline—Pain—Mycophenolate mofetil—systemic scleroderma	0.00205	0.00205	CcSEcCtD
Orciprenaline—Arrhythmia—Prednisone—systemic scleroderma	0.00204	0.00204	CcSEcCtD
Orciprenaline—Sweating—Methotrexate—systemic scleroderma	0.00204	0.00204	CcSEcCtD
Orciprenaline—Vomiting—Leflunomide—systemic scleroderma	0.00202	0.00202	CcSEcCtD
Orciprenaline—Hypersensitivity—Lisinopril—systemic scleroderma	0.00201	0.00201	CcSEcCtD
Orciprenaline—Dizziness—Mycophenolic acid—systemic scleroderma	0.002	0.002	CcSEcCtD
Orciprenaline—Nausea—Azathioprine—systemic scleroderma	0.002	0.002	CcSEcCtD
Orciprenaline—Headache—Leflunomide—systemic scleroderma	0.00199	0.00199	CcSEcCtD
Orciprenaline—Asthenia—Lisinopril—systemic scleroderma	0.00196	0.00196	CcSEcCtD
Orciprenaline—Pruritus—Lisinopril—systemic scleroderma	0.00193	0.00193	CcSEcCtD
Orciprenaline—Vomiting—Mycophenolic acid—systemic scleroderma	0.00193	0.00193	CcSEcCtD
Orciprenaline—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.0019	0.0019	CcSEcCtD
Orciprenaline—Headache—Mycophenolic acid—systemic scleroderma	0.0019	0.0019	CcSEcCtD
Orciprenaline—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.00189	0.00189	CcSEcCtD
Orciprenaline—Nausea—Leflunomide—systemic scleroderma	0.00189	0.00189	CcSEcCtD
Orciprenaline—Vision blurred—Prednisone—systemic scleroderma	0.00187	0.00187	CcSEcCtD
Orciprenaline—Diarrhoea—Lisinopril—systemic scleroderma	0.00187	0.00187	CcSEcCtD
Orciprenaline—Dizziness—Lisinopril—systemic scleroderma	0.00181	0.00181	CcSEcCtD
Orciprenaline—Nausea—Mycophenolic acid—systemic scleroderma	0.0018	0.0018	CcSEcCtD
Orciprenaline—Syncope—Prednisone—systemic scleroderma	0.00178	0.00178	CcSEcCtD
Orciprenaline—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.00176	0.00176	CcSEcCtD
Orciprenaline—Loss of consciousness—Prednisone—systemic scleroderma	0.00175	0.00175	CcSEcCtD
Orciprenaline—Vomiting—Lisinopril—systemic scleroderma	0.00174	0.00174	CcSEcCtD
Orciprenaline—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.00172	0.00172	CcSEcCtD
Orciprenaline—Hypertension—Prednisone—systemic scleroderma	0.00172	0.00172	CcSEcCtD
Orciprenaline—Chills—Methotrexate—systemic scleroderma	0.00171	0.00171	CcSEcCtD
Orciprenaline—Headache—Lisinopril—systemic scleroderma	0.00171	0.00171	CcSEcCtD
Orciprenaline—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.00169	0.00169	CcSEcCtD
Orciprenaline—Myalgia—Prednisone—systemic scleroderma	0.00169	0.00169	CcSEcCtD
Orciprenaline—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.00164	0.00164	CcSEcCtD
Orciprenaline—Dysgeusia—Methotrexate—systemic scleroderma	0.00163	0.00163	CcSEcCtD
Orciprenaline—Nausea—Lisinopril—systemic scleroderma	0.00162	0.00162	CcSEcCtD
Orciprenaline—Anaphylactic shock—Prednisone—systemic scleroderma	0.00162	0.00162	CcSEcCtD
Orciprenaline—Oedema—Prednisone—systemic scleroderma	0.00162	0.00162	CcSEcCtD
Orciprenaline—Shock—Prednisone—systemic scleroderma	0.0016	0.0016	CcSEcCtD
Orciprenaline—Tachycardia—Prednisone—systemic scleroderma	0.00158	0.00158	CcSEcCtD
Orciprenaline—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.00158	0.00158	CcSEcCtD
Orciprenaline—Hyperhidrosis—Prednisone—systemic scleroderma	0.00157	0.00157	CcSEcCtD
Orciprenaline—Vision blurred—Methotrexate—systemic scleroderma	0.00156	0.00156	CcSEcCtD
Orciprenaline—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.00152	0.00152	CcSEcCtD
Orciprenaline—Headache—Mycophenolate mofetil—systemic scleroderma	0.0015	0.0015	CcSEcCtD
Orciprenaline—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.00148	0.00148	CcSEcCtD
Orciprenaline—Insomnia—Prednisone—systemic scleroderma	0.00147	0.00147	CcSEcCtD
Orciprenaline—Cough—Methotrexate—systemic scleroderma	0.00145	0.00145	CcSEcCtD
Orciprenaline—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Orciprenaline—Chest pain—Methotrexate—systemic scleroderma	0.00141	0.00141	CcSEcCtD
Orciprenaline—Myalgia—Methotrexate—systemic scleroderma	0.00141	0.00141	CcSEcCtD
Orciprenaline—Fatigue—Prednisone—systemic scleroderma	0.0014	0.0014	CcSEcCtD
Orciprenaline—Anaphylactic shock—Methotrexate—systemic scleroderma	0.00136	0.00136	CcSEcCtD
Orciprenaline—Hyperhidrosis—Methotrexate—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Orciprenaline—Urticaria—Prednisone—systemic scleroderma	0.00129	0.00129	CcSEcCtD
Orciprenaline—Body temperature increased—Prednisone—systemic scleroderma	0.00128	0.00128	CcSEcCtD
Orciprenaline—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Orciprenaline—Insomnia—Methotrexate—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Orciprenaline—Somnolence—Methotrexate—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Orciprenaline—Hypersensitivity—Prednisone—systemic scleroderma	0.00119	0.00119	CcSEcCtD
Orciprenaline—Fatigue—Methotrexate—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Orciprenaline—Asthenia—Prednisone—systemic scleroderma	0.00116	0.00116	CcSEcCtD
Orciprenaline—Pain—Methotrexate—systemic scleroderma	0.00116	0.00116	CcSEcCtD
Orciprenaline—Pruritus—Prednisone—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Orciprenaline—Diarrhoea—Prednisone—systemic scleroderma	0.00111	0.00111	CcSEcCtD
Orciprenaline—Urticaria—Methotrexate—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Orciprenaline—Dizziness—Prednisone—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Orciprenaline—Body temperature increased—Methotrexate—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Orciprenaline—Vomiting—Prednisone—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Orciprenaline—Headache—Prednisone—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Orciprenaline—Hypersensitivity—Methotrexate—systemic scleroderma	0.000998	0.000998	CcSEcCtD
Orciprenaline—Asthenia—Methotrexate—systemic scleroderma	0.000972	0.000972	CcSEcCtD
Orciprenaline—Nausea—Prednisone—systemic scleroderma	0.000963	0.000963	CcSEcCtD
Orciprenaline—Pruritus—Methotrexate—systemic scleroderma	0.000959	0.000959	CcSEcCtD
Orciprenaline—Diarrhoea—Methotrexate—systemic scleroderma	0.000927	0.000927	CcSEcCtD
Orciprenaline—Dizziness—Methotrexate—systemic scleroderma	0.000896	0.000896	CcSEcCtD
Orciprenaline—Vomiting—Methotrexate—systemic scleroderma	0.000862	0.000862	CcSEcCtD
Orciprenaline—Headache—Methotrexate—systemic scleroderma	0.000849	0.000849	CcSEcCtD
Orciprenaline—Nausea—Methotrexate—systemic scleroderma	0.000805	0.000805	CcSEcCtD
